Skip to main content

Table 1 Characteristic of selected SNPs

From: Association between 28 single nucleotide polymorphisms and type 2 diabetes mellitus in the Kazakh population: a case-control study

SNP ID

Gene or nearby region

Location

Position

Traits

OR [95% CI]

References

rs3751812

FTO

16q12.2

Intron 1

Obesity

1.42 [1.33–1.52]

Frayling et al., 2007 [60]

rs8050136

FTO

16q12.2

Intron 1

T2DM; obesity

1.22 [1.07–1.40] 1.45 [1.09–1.93]

Liu et al., 2010 [26]

rs9939609

FTO

16q12.2

Intron 1

T2DM; obesity

1.19 [1.04–1.37]; 1.39 [1.04–1.85]

Liu et al., 2010 [26]

rs10811661

CDKN2A/B

9p21.3

Intergenic

T2DM

1.20 [1.14–1.25]

Zeggini et al., 2007 [27]

rs2383208

CDKN2A/B

9p21.3

Intergenic

T2DM

1.34 [1.27–1.41]

Takeuchi et al., 2009 [28]

rs1111875

HHEX

10q23.33

3′-UTR

T2DM

1.21 [1.15–1.28]

Takeuchi et al., 2009 [28]

rs5015480

HHEX

10q23.33

Intergenic

T2DM

1.17 [1.11–1.24]

Zegginietal., 2008

rs13266634

SLC30A8

8q24.11

Exon 8, missense

T2DM

1.16 [1.10–1.22]

Rung et al., 2009 [29], Takeuchi et al., 2009 [28]

rs4506565

TCF7L2

10q25.3

Intron 3

T2DM

1.36 [1.20–1.54]

Wellcome Trust Case Control Consortium (2007) [30]

rs7903146

TCF7L2

10q25.3

Intron 4

T2DM

1.49 [1.39–1.59]

Timpson et al., 2009 [31]

rs4402960

IGF2BP2

3q27.2

Intron 2

T2DM

1.14 [1.08–1.21]

Takeuchi et al., 2009 [28]

rs5215

KCNJ11

11p15.1

Exon 1

T2DM

1.16 [1.09–1.23]

Zeggini et al., 2008 [12]

rs7756992

CDKAL1

6p22.3

Intron 5

T2DM

1.20 [1.13–1.27]

Steinthorsdottir et al., 2007 [32]

rs4712523

CDKAL1

6p22.3

Intron 5

T2DM

1.27 [1.21–1.33]

Takeuchi et al., 2009 [28]

rs9465871

CDKAL1

6p22.3

Intron 5

T2DM

1.18 [1.04–1.34]

Wellcome Trust Case Control Consortium (2007) [30]

rs7961581

nearTSPAN8/LGR5

12q21.1

Intergenic

T2DM

1.09 [1.06–1.12]

Zeggini et al., 2008 [12]

rs864745

JAZF1

7p15.2-p15.1

Intron 1

T2DM

1.10 [1.07–1.13]

Zeggini et al., 2008 [12]

rs12779790

nearCDC123/CAMK1D

10p13

Intergenic

T2DM

1.11 [1.07–1.14]

Zeggini et al., 2008 [12]

rs10490072

BCL11A

2p16.1

3′ ofgene

T2DM

1.05 [1.03–1.08]

Zeggini et al., 2008 [12]

rs10923931

NOTCH2

1p13-p11

Intron 5

T2DM

1.13 [1.08–1.17]

Zeggini et al., 2008 [12]

rs7578597

THADA

2p21

Exon 24, missense

T2DM

1.15 [1.10–1.20]

Zeggini et al., 2008 [12]

rs2025804

LEPR

1p31

Intron 2

BMI

 

Traurig et al., 2012 [33]

rs2641348

ADAM30

1p12

Exon 1, missense

T2DM

1.10 [1.06–1.15]

Zeggini et al., 2008 [12]

rs9472138

near VEGFA

6p21.1

Intergenic

T2DM

1.06 [1.04–1.09]

Zeggini et al., 2008 [12]

rs1042714

ADRB2

5q31-q32

Exon 1, missense

T2DM

0.56 [0.36–0.91]

Pinelli et al., 2006 [34]

rs4994

ADRB3

8p12

Exon 1, missense

T2DM

1.27 [1.07–1.51]

Jing et al., 2012 [35]

rs1799883

FABP2

4q28-q31

Exon 2, missense

T2DM

1.29 [1.08–1.49]

Qiu et al., 2014 [8]

rs1801282

PPARG

3p25

Exon 4, missense

T2DM

1.14 [1.08–1.20]

Scott et al., 2007 [11]

rs8192678

PPARGC1A

4p15.1

Exon 8, missense

T2DM

1.07 [1.00–1.15]

Barroso et al., 2006 [37]

rs780094

GCKR

2p23

Intron 16

T2DM

0.71 [0.58–0.85]

Onuma et al., 2010 [38]

rs7944584

MADD

11p11.2

Intron 25

T2DM

1.63 [1.32–2.02]

Hu et al., 2010 [39]

rs1153188

DCD-VDAC1P5

12q13

Intergenic

T2DM

1.08 [1.05–1.11]

Zeggini et al., 2008 [12]